{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T23:05:01Z","timestamp":1795215901872,"version":"4.10.3"},"reference-count":61,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1857,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1111\/j.1399-3062.2009.00470.x","type":"journal-article","created":{"date-parts":[[2009,11,26]],"date-time":"2009-11-26T04:21:38Z","timestamp":1259209298000},"page":"292-308","source":"Crossref","is-referenced-by-count":91,"title":["Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis"],"prefix":"10.1111","volume":"12","author":[{"given":"L.H.","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.G.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Tur-Kaspa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,20]]},"reference":[{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB1|cit1","first-page":"959","volume-title":"Hepatology","author":"Nair","year":"2003"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB2|cit2","first-page":"656","article-title":"Survival and prognostic factors in 366 patients with compensated cirrhosis type B","volume":"21","author":"Realdi","year":"1994","journal-title":"a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP)"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1665-2681(19)32135-0","article-title":"Current therapies for chronic hepatitis B","volume":"2","author":"Buti","year":"2003","journal-title":"Ann Hepatol"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","article-title":"Liver transplantation in European patients with the hepatitis B surface antigen","volume":"329","author":"Samuel","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB5|cit5","first-page":"389","volume-title":"Clinics in Liver Disease","volume":"3","author":"Terrault","year":"1999"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/jhep.2001.21554","article-title":"A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B","volume":"33","author":"Perrillo","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00000658-199806000-00007","article-title":"Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization","volume":"227","author":"Sawyer","year":"1998","journal-title":"Ann Surg"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/00007890-199605150-00013","article-title":"Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization","volume":"61","author":"McGory","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/hep.510240601","article-title":"Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin","volume":"24","author":"Terrault","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.510280237","article-title":"Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin","volume":"28","author":"Terrault","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB11|cit11","first-page":"1189","article-title":"Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation","volume":"32","author":"Shouval","year":"2000","journal-title":"a concise review"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/jhep.2003.50294","article-title":"HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis","volume":"38","author":"Roche","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0140-6736(96)04444-3","article-title":"Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis","volume":"348","author":"Grellier","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB14|cit14","first-page":"809","article-title":"Lamivudine without HBIg for prevention of graft reinfection by hepatitis B","volume":"70","author":"Mutimer","year":"2000","journal-title":"long-term follow-up"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/hep.510280241","article-title":"Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin","volume":"28","author":"Markowitz","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0168-8278(03)00087-4","article-title":"A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation","volume":"38","author":"Buti","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/j.gastro.2007.01.005","article-title":"Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation","volume":"132","author":"Gane","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB18|cit18","unstructured":"Wells GA Shea B O'Connell D et al. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/01.tp.0000277289.23677.0a","article-title":"Adherence to lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrence","volume":"84","author":"Buti","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB21|cit21","first-page":"804","article-title":"Liver transplantation for chronic hepatitis B patients with lamivudine monotherapy or lamivudine combined with individualized low-dose hepatitis B immunoglobulin treatment","volume":"15","author":"Jiao","year":"2007","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB22|cit22","first-page":"345","article-title":"Prevention of hepatitis B virus reinfection after orthotopic liver transplantation","volume":"3","author":"Wang","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1053\/jhep.2002.33681","article-title":"Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease","volume":"35","author":"Steinm\u00fcller","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/S0041-1345(01)02567-2","article-title":"Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine","volume":"33","author":"Lee","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/S0041-1345(00)01786-3","article-title":"Prophylaxis against hepatitis B recurrence following liver transplantation in HBs Ag(+) patients","volume":"32","author":"Lee","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1053\/j.gastro.2008.02.064","article-title":"Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation","volume":"134","author":"Faria","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB27|cit27","first-page":"28","article-title":"Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin","volume":"12","author":"Oldakowska-Jedynak","year":"2007","journal-title":"Ann Transplant"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3748\/wjg.v12.i11.1706","article-title":"Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease","volume":"12","author":"Targhetta","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1096-9071(200001)60:1<8::AID-JMV2>3.0.CO;2-U","article-title":"Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients","volume":"60","author":"Seta","year":"2000","journal-title":"J Med Virol"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/lt.20217","article-title":"Outcome of liver transplantation for hepatitis B in the United States","volume":"10","author":"Kim","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1053\/jlts.2000.6446","article-title":"Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation","volume":"6","author":"Dodson","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.tp.0000264001.69308.be","article-title":"Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection","volume":"83","author":"Caccamo","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB33|cit33","first-page":"26","article-title":"Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation","volume":"3","author":"Lu","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB34|cit34","first-page":"510","article-title":"Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation","volume":"21","author":"Anderson","year":"2007","journal-title":"comparison with other HBIG regimens"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB35|cit35","first-page":"1105","article-title":"Viral persistence after liver transplantation for hepatitis B virus","volume":"85","author":"Freshwater","year":"2008","journal-title":"a cross-sectional study"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1016\/j.transproceed.2007.07.085","article-title":"Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B","volume":"39","author":"Zimmerman","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB37|cit37","first-page":"349","article-title":"Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B","volume":"13","author":"Schiff","year":"2007","journal-title":"final long-term results"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB38|cit38","first-page":"999","article-title":"Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation","volume":"3","author":"Dumortier","year":"2003","journal-title":"long-term results"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB39|cit39","first-page":"512","article-title":"Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection","volume":"5","author":"McCaughan","year":"1999","journal-title":"high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/lt.21043","article-title":"Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation","volume":"13","author":"Yi","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/jlts.2000.18702","article-title":"An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy","volume":"6","author":"Han","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/jlts.2001.28442","article-title":"Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation","volume":"7","author":"Seehofer","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB43|cit43","first-page":"72","article-title":"Prophylaxsis against recurrance of hepatitis B virus after liver transplantation","volume":"28","author":"Yilmaz","year":"2008","journal-title":"a retrospective analysis spanning 20 years"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0041-1345(03)00008-3","article-title":"Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients","volume":"35","author":"Ben-Ari","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0041-1345(03)00065-4","article-title":"Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation","volume":"35","author":"Sousa","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1399-3062.2002.01012.x","article-title":"Evolving experience of hepatitis B virus prophylaxis in liver transplantation","volume":"4","author":"Honaker","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/lt.20701","article-title":"Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis","volume":"12","author":"Zheng","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB48|cit48","first-page":"1372","article-title":"Outcomes in liver transplant recipients with hepatitis B virus","volume":"10","author":"Neff","year":"2004","journal-title":"resistance and recurrence patterns from a large transplant center over the last decade"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.transproceed.2007.03.062","article-title":"Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen","volume":"39","author":"Jiao","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.transproceed.2004.07.070","article-title":"Prevention of hepatitis B virus reinfection after orthotopic liver transplantation","volume":"36","author":"Wang","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-0012.2006.00557.x","article-title":"Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection","volume":"21","author":"Yoshida","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB52|cit52","first-page":"500","article-title":"Prevention and treatment of hepatitis B recurrence after liver transplantation","volume":"2","author":"Zhu","year":"2003","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0041-1345(02)02637-4","article-title":"Is lamivudine with 1-week HBIg as effective as long-term high-dose HBIg in HBV prophylaxis after liver transplantation?","volume":"34","author":"Park","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0168-8278(01)00039-3","article-title":"Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation","volume":"34","author":"Naoumov","year":"2001","journal-title":"J Hepatol"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB55|cit55","first-page":"611","article-title":"New era of liver transplantation for hepatitis B","volume":"235","author":"Anselmo","year":"2002","journal-title":"a 17-year single-center experience"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0168-8278(03)00396-9","article-title":"Prophylaxis with anti-HBs immune globulins and nucleoside analogues after liver transplantation for HBV infection","volume":"39","author":"Villamil","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB57|cit57","first-page":"8","article-title":"Prevention and treatment of recurrent hepatitis B after liver transplantation","volume":"5","author":"Schreibman","year":"2006","journal-title":"the current role of nucleoside and nucleotide analogues"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB59|cit59","first-page":"716","article-title":"Management of the hepatitis B virus in the liver transplantation setting","volume":"11","author":"Terrault","year":"2005","journal-title":"a European and an American perspective"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB60|cit60","first-page":"696","article-title":"Hepatitis B immunoglobulin and lamivudine improve hepatitis B-related outcomes after liver transplantation","volume":"6","author":"Loomba","year":"2008","journal-title":"meta-analysis"},{"key":"10.1111\/j.1399-3062.2009.00470.x-BIB61|cit61","first-page":"387","article-title":"Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation","volume":"22","author":"Rao","year":"2009","journal-title":"a meta-analysis"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2009.00470.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-3062.2009.00470.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T01:30:37Z","timestamp":1625621437000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2009.00470.x"}},"subtitle":["Post liver transplant hepatitis B prophylaxis"],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2009.00470.x","relation":{},"ISSN":["1398-2273"],"issn-type":[{"value":"1398-2273","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}